<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:st1="urn:schemas-microsoft-com:office:smarttags"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=iso-8859-1">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="Lighting_CARS_files/filelist.xml">
<link rel=Edit-Time-Data href="Lighting_CARS_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title>Untitled Document</title>
<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags"
 name="PlaceType"/>
<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags"
 name="PlaceName"/>
<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags"
 name="City"/>
<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags"
 name="place"/>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>ILPB User</o:Author>
  <o:LastAuthor>ILPB User</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>2</o:TotalTime>
  <o:Created>2008-09-26T20:39:00Z</o:Created>
  <o:LastSaved>2008-09-26T20:41:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>1070</o:Words>
  <o:Characters>6104</o:Characters>
  <o:Company>University at Buffalo</o:Company>
  <o:Lines>50</o:Lines>
  <o:Paragraphs>14</o:Paragraphs>
  <o:CharactersWithSpaces>7160</o:CharactersWithSpaces>
  <o:Version>11.9999</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]--><!--[if !mso]><object
 classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></object>
<style>
st1\:*{behavior:url(#ieooui) }
</style>
<![endif]-->
<style>
<!--
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<p class=MsoNormal>A. V. <span class=SpellE>Kachynski</span>, A. N. <span
class=SpellE>Kuzmin</span>, P. N. Prasad, I. I. <span class=SpellE>Smalyukh</span>.
<span class=GramE>&#8220;Coherent Anti-Stokes Raman Scattering Polarized
Microscopy of Three-dimensional Director Structures in Liquid Crystals&#8221;.</span>
/Applied Physics Letters /, *91* (2007) #151905. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>In the latest issue of Applied Physics Letters, a new
approach to imaging of director fields in liquid crystals is reported by a
collaborative research team from the University at <st1:City w:st="on">Buffalo</st1:City>
and the <st1:PlaceType w:st="on">University</st1:PlaceType> of <st1:PlaceName
w:st="on">Colorado</st1:PlaceName> at <st1:City w:st="on"><st1:place w:st="on">Boulder</st1:place></st1:City>.
<span class=SpellE>Kachynski</span>, <span class=SpellE>Kuzmin</span>, Prasad
and <span class=SpellE>Smalyukh</span> report the 3-D imaging of LC director
structures using coherent anti-Stokes Raman scattering (CARS) microscopy. This
method utilizes active <span class=SpellE>vibrational</span> Raman scattering
to generate contrast signal and does not require doping the liquid crystal with
dyes. It offers fast image acquisition, chemical selectivity and
bond-orientation specificity that are all superior to that of other techniques.
<o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>In order to demonstrate that the contrast in CARS polarized
microscopy textures arises due to molecular orientation <span class=GramE>patterns,</span>
researchers use a single-compound liquid crystal material and decipher a
typical 3D director structure. Determined by the angle between the selected
chemical bond and the polarization of the probe beam, the measured CARS signal
intensity pattern describes the director field&#8217;s spatial configuration.
The technique provides 100,000 times faster imaging than the <span
class=SpellE>confocal</span> Raman microscopy. Researchers demonstrate that the
CARS polarized microscopy (CARS-PM) is a viable technique for mapping of the
3-D patterns of molecular orientations and LC director dynamics. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Fast image acquisition and short CARS signal integration
times can allow one to study temporal dynamics of director structures in liquid
crystal displays. Selective sensitivity to oscillations makes CARS microscopy
especially attractive for imaging of different LC directors in biaxial <span
class=SpellE>nematics</span> and <span class=SpellE>smectics</span> by using
different chemical bonds of the biaxial LC molecules. The article by <span
class=SpellE>Kachynski</span> et al. demonstrates that CARS microscopy can be
successfully used not only for visualizing chemical composition and bond
orientation in biological and <span class=SpellE>lyotropic</span> systems, but
also in materials of technological importance (liquid crystals), and that CARS
images can reveal molecular orientations even in the case if a material is
composed of a single chemical compound. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>These researchers are currently using the technique to probe
director patterns in multi-component heterogeneous systems such as LC colloids,
anisotropic polymers, and <span class=SpellE>nanoparticle</span>-LC composite
materials, which are now widely viewed as promising materials to build a
variety of tunable optical <span class=SpellE>metamaterials</span>. The
technique will allow one to explore how <span class=SpellE>nano</span>-sized
inclusions and <span class=SpellE>microparticles</span> alter the director
field of these ordered soft materials and what the structures of induced
defects around the inclusions. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>http://scitation.aip.org/journals/doc/APPLAB-ft/vol_91/iss_15/151905_1.html<o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Figure: 3D focal conic domain director structure has been
reconstructed using a series of XY images obtained in the F-CARS mode at
different depths of sample and with 1 mm step in Z-direction <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:3in;
 height:189pt'>
 <v:imagedata src="Lighting_CARS_files/image001.jpg" o:title="1"/>
</v:shape><![endif]--><![if !vml]><img width=288 height=252
src="Lighting_CARS_files/image002.jpg" v:shapes="_x0000_i1025"><![endif]></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>No Carrier Necessary: This Drug Delivers Itself <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Release Date March 8, 2007 <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>By ELLEN GOLDBAUM <o:p></o:p></p>

<p class=MsoNormal>Contributing Editor <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>The problem of efficiently delivering drugs, especially
those that are hydrophobic or water-repellant, to tumors or other disease sites
has long challenged scientists to develop innovative delivery systems that keep
these drugs intact until reaching their targets. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><!--[if gte vml 1]><v:shape id="_x0000_i1026" type="#_x0000_t75"
 style='width:200.25pt;height:200.25pt'>
 <v:imagedata src="Lighting_CARS_files/image003.jpg" o:title="news_clip_image003"/>
</v:shape><![endif]--><![if !vml]><img width=267 height=267
src="Lighting_CARS_files/image004.jpg" v:shapes="_x0000_i1026"><![endif]></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><span class=SpellE>Confocal</span> microscope image shows
uptake of the <span class=SpellE>nanocrystals</span> by cancer cells.<o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Now scientists in <span class=SpellE>UB's</span> Institute
for Lasers, Photonics and <span class=SpellE>Biophotonics</span> and Roswell
Park Cancer Institute have developed an innovative solution in which the
delivery system is the drug itself. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>They describe for the first time in Molecular Pharmaceutics
a drug-delivery system that consists of <span class=SpellE>nanocrystals</span>
of a hydrophobic drug. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>The system involves the use of <span class=SpellE>nanocrystals</span>
measuring about 100 nanometers of pure HPPH (2-devinyl-2-(1'-hexyloxyethyl) <span
class=SpellE>pyropheophorbide</span>), a <span class=SpellE>photosensitizer</span>
currently in Phase I/II human clinical trials at RPCI for treating various
types of cancer. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>The UB researchers found that the <span class=SpellE>nanocrystals</span>
of HPPH were taken up by tumors in vivo, with efficacy comparable to conventional,
surfactant-based delivery systems. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>A patent has been filed on this work. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>&quot;In this case, the drug itself acts as its own
carrier,&quot; said <span class=SpellE>Haridas</span> <span class=SpellE>Pudavar</span>,
UB research assistant professor of chemistry and a co-author. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>The <span class=SpellE>nanocrystals</span> present a major
advantage over methods of delivery involving other carriers, according to <span
class=SpellE>Paras</span> Prasad, SUNY Distinguished Professor in the
Department of Chemistry in the <st1:place w:st="on"><st1:PlaceType w:st="on">College</st1:PlaceType>
 of <st1:PlaceName w:st="on">Arts</st1:PlaceName></st1:place> and Sciences,
executive director of the institute and a co-author. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Because other delivery systems, especially those containing
surfactants, commonly used with HPPH and many other drugs may add to the
toxicity in the body, they have been considered imperfect solutions. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>&quot;Unlike formulations that require separate delivery
systems, once this drug is approved, no additional approvals will be
needed,&quot; said Prasad. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>&quot;Our published data in animal models demonstrate no
difference in drug activity with the <span class=SpellE>nanocrystal</span>
formulation,&quot; said <span class=SpellE>Ravindra</span> <span class=SpellE>Pandey</span>,
Distinguished Professor of biophysical sciences at RPCI and a co-author on the
paper. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>&quot;This is a case where the easiest formulation works the
best,&quot; added <span class=SpellE>Indrajit</span> Roy, UB research assistant
professor of chemistry and another co-author. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>The researchers found that because HPPH is <span
class=SpellE>amphiphillic</span>, i.e. partially soluble in water and oil, <span
class=SpellE>nanocrystals</span> of it will self-assemble; that is, in solution
the molecules aggregate, but not into such big clusters that they settle to the
bottom. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>&quot;It's a controlled formation of a <span class=SpellE>colloidally</span>
stable suspension of <span class=SpellE>nanosized</span> crystals,&quot;
explained <span class=SpellE>Tymish</span> <span class=SpellE>Ohulchanskyy</span>,
UB senior research scientist and a co-author. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>The researchers originally were investigating <span
class=SpellE>nanocrystals</span> as a delivery method for hydrophobic dyes in <span
class=SpellE>bioimaging</span> applications, another promising use for <span
class=SpellE>nanocrystals</span> that they continue to pursue. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Further in vivo studies with HPPH <span class=SpellE>nanocrystals</span>
are being conducted by scientists at UB and RPCI, including <span class=SpellE>Pandey</span>
and Allan R. <span class=SpellE>Oseroff</span>, chair of the Department of
Dermatology at RPCI and in <span class=SpellE>UB's</span> <st1:place w:st="on"><st1:PlaceType
 w:st="on">School</st1:PlaceType> of <st1:PlaceName w:st="on">Medicine</st1:PlaceName></st1:place>
and Biomedical Sciences. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>The UB-RPCI team is exploring the use of the same technique
for delivering other hydrophobic drugs, including those used in chemotherapy. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Additional co-authors on the paper are Koichi Baba, former
postdoctoral research associate in the UB Department of Chemistry, and <span
class=SpellE>Yihui</span> Chen, postdoctoral research associate at RPCI. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>The <span class=SpellE>nanocrystal</span> research was
supported by the National Institutes of Health, the John R. <span class=SpellE>Oishei</span>
Foundation and <span class=SpellE>UB's</span> New York State Center of
Excellence in Bioinformatics and Life Sciences, with additional support from
RPCI. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>In related work, the UB researchers have achieved improved
depth penetration of HPPH using two-photon photodynamic therapy, research that
recently was published in the Journal of the American Chemical Society.<o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

</div>

</body>

</html>
